Pathological complete response to neoadjuvant ceritinib of a crizotinib-resistant, stage IIIB non-small cell lung cancer with ALK rearrangement: A case report

Bing, ZX; Jia, ZQ; Wang, YD; Xue, JC; Cao, L; Cao, ZL; Liu, P; Li, J; Liang, NX; Li, SQ

Liang, NX (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Thorac Surg, 1 Shuaifuyuan, Beijing 100730, Peoples R China.

THORACIC CANCER, 2021; 12 (14): 2130

Abstract

The treatment of stage IIIB non-small cell lung cancer (NSCLC) is complicated, the best strategy is chosen individually and surgery is usually not rec......

Full Text Link